[Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile].
Antiretroviral therapy has changed the course of HIV epidemic, as consequence, the patients present the same medical conditions than the rest ofthe population, including cardiovascular diseases.


OBJECTIVE
To describe the evolution of cardiovascular risk of HIV positive patients attending to a HIV/AIDS integral clinical center. Clinical charts were reviewed, looking for cardiovascular risk markers. Our findings showed a deficient evaluation of the cardiovascular basal risks at first medical control and patients had important metabolic alterations despite hypolipidemic treatment. Given the higher cardiovascular risk of this population, increasing the effort on diagnosis and treatment of HIV patients is required.
Facultad de Medicina, Universidad de Chile, Chile.
Camila
C
Lazcano
Facultad de Medicina, Universidad de Chile, Chile.
Juan C
JC
Millacura
Facultad de Medicina, Universidad de Chile, Chile.
Felipe
F
Saavedra
Facultad de Medicina, Universidad de Chile,, Chile, cpcortesm@med.uchile.cl.
Claudia P
CP
Cortés
D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000378:metabolism*; D002677:Chile; D002784:Cholesterol / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008499:Medical Records; D012189:Retrospective Studies; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D044966:Anti-Retroviral Agents; D000960:Hypolipidemic Agents; D014280:Triglycerides; D002784:Cholesterol